{"database": "lobbying", "table": "lobbying_activities", "rows": [[3141241, "0c3fda88-cb4d-41d4-be54-dcc8df9ff64f", "Q1", "TRUSYNERGY", 401107715, "BURRELL INTERNATIONAL GROUP (ON BEHALF OF ARSENAL MEDICAL, INC.)", 2024, "first_quarter", "MED", "Funding for medical devices for hemorrhages; provisions in FY24 NDAA and FY24 Defense Appropriations", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2024-04-10T06:29:24-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3141241"], "units": {}, "query_ms": 0.4383510095067322, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}